BCM
TXG icon

Bridgeway Capital Management’s 10x Genomics TXG Stock Holding History

Bridgeway Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
+80,000
New +$2.1M 0.05% 435
2021
Q1 		– Sell
-19,600
Closed -$2.77M – 1412
2020
Q4 		$2.77M Hold
19,600
– – 0.06% 397
2020
Q3 		$2.44M Buy
+19,600
New +$2.06M 0.06% 354

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgeway Capital Management's TXG Position: Q2 2026 in Review

Bridgeway Capital Management opened a new position in 10x Genomics (TXG) in Q2 2026: 80,000 shares worth $3.07M. The stake represents 0.05% of the portfolio and ranks #435 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in TXG as recently as Q4 2020.

Bridgeway Capital Management first reported a position in TXG in Q3 2020 and has held it in 3 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bridgeway Capital Management held 80,000 shares of 10x Genomics worth $3.07M as of Q2 2026.
  • 10x Genomics was a new Bridgeway Capital Management position in Q2 2026.
  • 10x Genomics made up 0.05% of Bridgeway Capital Management's portfolio in Q2 2026, its #435 holding.
  • Bridgeway Capital Management first reported a position in 10x Genomics in Q3 2020 and has held it in 3 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.